Organization
MetrioPharm
1 clinical trial
Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter, Proof-of-concept, Phase IIA Study of MP1032 Plus Standard of Care vs Standard of Care in the Treatment of Hospitalized Participants With Moderate to Severe COVID-19Status: Completed, Estimated PCD: 2022-07-28